Published in Int J Cancer on January 15, 2010
A case-control study on risk factors of breast cancer in China. Arch Med Sci (2012) 1.04
Milk, dairy intake and risk of endometrial cancer: a 26-year follow-up. Int J Cancer (2011) 0.90
Maternal BMI, IGF-I Levels, and Birth Weight in African American and White Infants. Int J Pediatr (2013) 0.78
Dietary intake of vitamin B(6) and risk of breast cancer in Taiwanese women. J Epidemiol (2011) 0.76
Potential Mechanisms underlying the Protective Effect of Pregnancy against Breast Cancer: A Focus on the IGF Pathway. Front Oncol (2016) 0.75
Newly discovered breast cancer susceptibility loci on 3p24 and 17q23.2. Nat Genet (2009) 7.30
Hepatitis B e antigen and the risk of hepatocellular carcinoma. N Engl J Med (2002) 6.20
Associations of breast cancer risk factors with tumor subtypes: a pooled analysis from the Breast Cancer Association Consortium studies. J Natl Cancer Inst (2010) 4.54
Multiple independent variants at the TERT locus are associated with telomere length and risks of breast and ovarian cancer. Nat Genet (2013) 4.35
Genome-wide association studies identify four ER negative-specific breast cancer risk loci. Nat Genet (2013) 3.81
Genome-wide association analysis identifies three new breast cancer susceptibility loci. Nat Genet (2012) 3.20
Risk of estrogen receptor-positive and -negative breast cancer and single-nucleotide polymorphism 2q35-rs13387042. J Natl Cancer Inst (2009) 2.88
Clinical entity and treatment strategies for adult intussusceptions: 20 years' experience. Dis Colon Rectum (2007) 2.76
Low penetrance breast cancer susceptibility loci are associated with specific breast tumor subtypes: findings from the Breast Cancer Association Consortium. Hum Mol Genet (2011) 2.72
Metabolic factors and risk of hepatocellular carcinoma by chronic hepatitis B/C infection: a follow-up study in Taiwan. Gastroenterology (2008) 2.46
TET1 suppresses cancer invasion by activating the tissue inhibitors of metalloproteinases. Cell Rep (2012) 2.20
C-reactive protein concentration as a significant correlate for metabolic syndrome: a Chinese population-based study. Endocrine (2012) 2.19
19p13.1 is a triple-negative-specific breast cancer susceptibility locus. Cancer Res (2012) 1.81
Cystic lymphangioma of the jejunal mesentery in an adult: a case report. World J Gastroenterol (2005) 1.76
Single nucleotide polymorphism at Fas promoter is associated with cervical carcinogenesis. Int J Cancer (2003) 1.71
Carriers of inactive hepatitis B virus are still at risk for hepatocellular carcinoma and liver-related death. Gastroenterology (2010) 1.69
Aggressive hepatic resection for patients with pyogenic liver abscess and APACHE II score > or =15. Am J Surg (2008) 1.63
Association of ESR1 gene tagging SNPs with breast cancer risk. Hum Mol Genet (2009) 1.58
Associations of common variants at 1p11.2 and 14q24.1 (RAD51L1) with breast cancer risk and heterogeneity by tumor subtype: findings from the Breast Cancer Association Consortium. Hum Mol Genet (2011) 1.56
Does previous abdominal surgery increase postoperative complication rates in continuous ambulatory peritoneal dialysis? Perit Dial Int (2007) 1.53
Ultrasound screening and risk factors for death from hepatocellular carcinoma in a high risk group in Taiwan. Int J Cancer (2002) 1.48
Unusual presentation of cystic liver metastases from nasopharyngeal carcinoma. Onkologie (2008) 1.46
Expression of Globo H and SSEA3 in breast cancer stem cells and the involvement of fucosyl transferases 1 and 2 in Globo H synthesis. Proc Natl Acad Sci U S A (2008) 1.43
A safe and effective method to implant a totally implantable access port in patients with synchronous bilateral mastectomies: modified femoral vein approach. J Surg Oncol (2008) 1.43
Identification of novel DNA methylation markers in cervical cancer. Int J Cancer (2008) 1.42
Epigenetic silencing of SFRP5 is related to malignant phenotype and chemoresistance of ovarian cancer through Wnt signaling pathway. Int J Cancer (2010) 1.40
Midgut volvulus in an adult with congenital malrotation. Am J Surg (2008) 1.38
Common genetic determinants of breast-cancer risk in East Asian women: a collaborative study of 23 637 breast cancer cases and 25 579 controls. Hum Mol Genet (2013) 1.38
Evaluation of serum amyloid A as a biomarker for gastric cancer. Ann Surg Oncol (2006) 1.37
MicroRNA-30a inhibits cell migration and invasion by downregulating vimentin expression and is a potential prognostic marker in breast cancer. Breast Cancer Res Treat (2012) 1.37
Genetic variants of BLM interact with RAD51 to increase breast cancer susceptibility. Carcinogenesis (2008) 1.34
Breast cancer risk is associated with the genes encoding the DNA double-strand break repair Mre11/Rad50/Nbs1 complex. Cancer Epidemiol Biomarkers Prev (2007) 1.34
Glycan microarray of Globo H and related structures for quantitative analysis of breast cancer. Proc Natl Acad Sci U S A (2008) 1.33
Intrauterine contraceptive device appendicitis: a case report. World J Gastroenterol (2005) 1.33
Anthropometric measures, plasma adiponectin, and breast cancer risk. Endocr Relat Cancer (2007) 1.31
Five polymorphisms and breast cancer risk: results from the Breast Cancer Association Consortium. Cancer Epidemiol Biomarkers Prev (2009) 1.29
Oxidized cellulose (Surgicel) granuloma mimicking a primary ovarian tumor. Int J Gynecol Pathol (2002) 1.27
11q13 is a susceptibility locus for hormone receptor positive breast cancer. Hum Mutat (2012) 1.26
Breast cancer risk associated with genotype polymorphism of the catechol estrogen-metabolizing genes: a multigenic study on cancer susceptibility. Int J Cancer (2005) 1.25
Uric acid level as a risk marker for metabolic syndrome: a Chinese cohort study. Atherosclerosis (2011) 1.24
Confirmation of 5p12 as a susceptibility locus for progesterone-receptor-positive, lower grade breast cancer. Cancer Epidemiol Biomarkers Prev (2011) 1.23
Risk of hepatocellular carcinoma and habits of alcohol drinking, betel quid chewing and cigarette smoking: a cohort of 2416 HBsAg-seropositive and 9421 HBsAg-seronegative male residents in Taiwan. Cancer Causes Control (2003) 1.23
An epigenetic marker panel for screening and prognostic prediction of ovarian cancer. Int J Cancer (2009) 1.22
Breast cancer risk associated with genotypic polymorphism of the nonhomologous end-joining genes: a multigenic study on cancer susceptibility. Cancer Res (2003) 1.21
The effectiveness of benzydamine hydrochloride spraying on the endotracheal tube cuff or oral mucosa for postoperative sore throat. Anesth Analg (2010) 1.19
Comparing hepatic resection and transarterial chemoembolization for Barcelona Clinic Liver Cancer (BCLC) stage B hepatocellular carcinoma: change for treatment of choice? World J Surg (2010) 1.17
Seroprevalence of human papillomaviruses and Chlamydia trachomatis and cervical cancer risk: nested case-control study. J Gen Virol (2007) 1.16
Ectopic pancreas presenting as ampulla of Vater tumor. Am J Surg (2008) 1.14
Bilateral superficial cervical plexus block combined with general anesthesia administered in thyroid operations. World J Surg (2010) 1.14
Comparison of 6q25 breast cancer hits from Asian and European Genome Wide Association Studies in the Breast Cancer Association Consortium (BCAC). PLoS One (2012) 1.13
Genetic polymorphisms of the methylenetetrahydrofolate reductase gene, plasma folate levels and breast cancer susceptibility: a case-control study in Taiwan. Carcinogenesis (2006) 1.12
Breast cancer risk associated with genotypic polymorphism of the mitosis-regulating gene Aurora-A/STK15/BTAK. Int J Cancer (2005) 1.12
Malignant mesenchymal tumor with leiomyosarcoma, rhabdomyosarcoma, chondrosarcoma, and osteosarcoma differentiation: case report and literature review. Diagn Pathol (2011) 1.11
Breast cancer risk and the DNA double-strand break end-joining capacity of nonhomologous end-joining genes are affected by BRCA1. Cancer Res (2004) 1.11
Thyroidectomy for Hashimoto's thyroiditis: complications and associated cancers. Thyroid (2008) 1.11
Prognostic significance of global histone modifications in resected squamous cell carcinoma of the esophagus. Mod Pathol (2008) 1.07
Detection of multidrug-resistant Salmonella enterica serovar typhimurium phage types DT102, DT104, and U302 by multiplex PCR. J Clin Microbiol (2006) 1.06
Management of spontaneously ruptured hepatocellular carcinoma and hemoperitoneum manifested as acute abdomen in the emergency room. World J Surg (2012) 1.06
Prevalence of metabolically healthy obesity and its impacts on incidences of hypertension, diabetes and the metabolic syndrome in Taiwan. Asia Pac J Clin Nutr (2012) 1.04
High-resolution 19p13.2-13.3 allelotyping of breast carcinomas demonstrates frequent loss of heterozygosity. Genes Chromosomes Cancer (2004) 1.04
Diverticulosis of the jejunum with intestinal obstruction: A case report. World J Gastroenterol (2005) 1.04
SAHA inhibits the growth of colon tumors by decreasing histone deacetylase and the expression of cyclin D1 and survivin. Pathol Oncol Res (2012) 1.02
Adipocytokine resistin and breast cancer risk. Breast Cancer Res Treat (2010) 1.02
Malignant perivascular epithelioid cell tumor of the mesentery: a case report and literature review. Onkologie (2012) 1.02
Loss of corepressor PER2 under hypoxia up-regulates OCT1-mediated EMT gene expression and enhances tumor malignancy. Proc Natl Acad Sci U S A (2013) 1.00
Genetic variation in the premature aging gene WRN: a case-control study on breast cancer susceptibility. Cancer Epidemiol Biomarkers Prev (2007) 1.00
Superselective transarterial chemoembolization vs hepatic resection for resectable early-stage hepatocellular carcinoma in patients with Child-Pugh class a liver function. Eur J Radiol (2011) 0.99
Tartrate-resistant acid phosphatase 5b is a useful serum marker for extensive bone metastasis in breast cancer patients. Clin Cancer Res (2005) 0.99
Genetic variation in the genome-wide predicted estrogen response element-related sequences is associated with breast cancer development. Breast Cancer Res (2011) 0.98
Expression of hypoxia-inducible factor (HIF)-1alpha and vascular endothelial growth factor (VEGF)-D as outcome predictors in resected esophageal squamous cell carcinoma. Dis Markers (2008) 0.97
Uric acid concentration as a risk marker for blood pressure progression and incident hypertension: a Chinese cohort study. Metabolism (2012) 0.97
Genetic susceptibility to the development and progression of breast cancer associated with polymorphism of cell cycle and ubiquitin ligase genes. Carcinogenesis (2009) 0.97